Currently out of the existing stock ratings of Jonathan Yong, 53 are a BUY (42.4%), 64 are a HOLD (51.2%), 8 are a SELL (6.4%).

Jonathan Yong

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Yong, currently employed at UBS, carries an average stock price target met ratio of 66.41% that have a potential upside of 17.74% achieved within 195 days.

Jonathan Yong’s has documented 261 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.

Most recent stock forecast was given on OSCR, Oscar Health at 12-Oct-2026.

Wall Street Analyst Jonathan Yong

Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.

Average potential price target upside

of $81.77 (19.03%) on HUM (HUMANA).
of $59.65 (28.52%) on HCA (HCA HOLDINGS).
of $54.36 (15.48%) on MCK (MCKESSON).

OSCR Oscar Health AMED Amedisys CHNG Change Healthcare CVS CVS Health Corp GOCO GoHealth HCA HCA Holdings LH Laboratory of America Holdings LHCG LHC Group MOH Molina Healthcare WBA Walgreens Boots Alliance THC Tenet Healthcare ACCD Accolade CI Cigna Corp CNC Centene Corp GDRX Goodrx Holdings HIMS Hims Hers Health HUM Humana MCK McKesson TDOC Teladoc DH Definitive Healthcare Corp AMN AMN Healthcare Services CLOV Clover Health Investments Corp CYH Community Health Systems EHAB Enhabit EHTH eHealth HSIC Henry Schein OMI Owens & Minor PRVA Privia Health Group CAH Cardinal Health EHC Encompass Health Corp HCSG Healthcare Services Group PDCO Patterson Companies PINC Premier SEM Select Medical Holdings UHS Universal Health Services

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jonathan Yong (UBS)

Hold Since 11-Feb-2026

$36

$4.11 (12.89%)

$20

10 days ago
(12-Oct-2026)

9/11 (81.82%)

$2.63 (7.88%)

174

Please subscribe to see extended stock data

John Ransom (RAYMOND JAMES)

Buy Since 21-Mar-2024

$42

$10.11 (31.70%)

1 months 4 days ago
(18-Sep-2026)

1/2 (50%)

$9.87 (30.72%)

Please subscribe to see extended stock data

Michael Ha (BAIRD)

Hold Since 07-May-2026

$33

$1.11 (3.48%)

$19

1 months 5 days ago
(17-Sep-2026)

1/2 (50%)

$1.02 (3.19%)

Please subscribe to see extended stock data

Andrew Mok (BARCLAYS)

Buy Since 07-Aug-2026

$49

$17.11 (53.65%)

$39

1 months 5 days ago
(17-Sep-2026)

6/9 (66.67%)

$17.02 (53.22%)

Please subscribe to see extended stock data

Stephen Baxter (WELLS FARGO)

Hold Since 13-Aug-2026

$27

$-4.89 (-15.33%)

$20

2 months 9 days ago
(13-Aug-2026)

7/10 (70%)

$-3.78 (-12.28%)

737

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Jonathan Yong most bullish on?

Potential upside of $4.11 has been obtained for OSCR (OSCAR HEALTH)

Which stock is Jonathan Yong most reserved on?

Potential downside of $0.52 has been obtained for CLOV (CLOVER HEALTH INVESTMENTS CORP)

What Year was the first public recommendation made by Jonathan Yong?

On 2017